Trial
NCT00785798
Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Merck Sharp & Dohme LLC
Condition
Relapsed Lymphomas
Intervention
Vorinostat
Why stopped
sponsor requested
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-04